Found: 15
Select item for more details and to access through your institution.
Untitled.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 4, p. 213, doi. 10.1254/fpj.22030
- By:
- Publication type:
- Article
Pharmacological actions of anifrolumab (Saphnelo®) and clinical trial results as a treatment for systemic lupus erythematosus.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 4, p. 271, doi. 10.1254/fpj.22026
- By:
- Publication type:
- Article
Untitled.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 4, p. 232, doi. 10.1254/fpj.22025
- By:
- Publication type:
- Article
Untitled.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 4, p. 280, doi. 10.1254/fpj.22024
- Publication type:
- Article
Untitled.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 4, p. 248, doi. 10.1254/fpj.22023
- By:
- Publication type:
- Article
Treatment of COVID-19.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 4, p. 214, doi. 10.1254/fpj.22019
- By:
- Publication type:
- Article
Challenges in drug discovery research and the effects of SGLT2 inhibitor against diabetic kidney disease.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 4, p. 249, doi. 10.1254/fpj.22008
- By:
- Publication type:
- Article
New trend in genotoxicity research taking into account genome instability.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 4, p. 265, doi. 10.1254/fpj.22015
- By:
- Publication type:
- Article
Vascular hyperpermeable molecules potentially contributing to the development of pulmonary edema in sepsis-associated ARDS.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 4, p. 229, doi. 10.1254/fpj.22013
- By:
- Publication type:
- Article
A novel ligand for chemogenetic receptors, Deschloroclozapine, enables rapid and selective modulation of neuronal activity and behavior in living animals.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 4, p. 233, doi. 10.1254/fpj.22012
- By:
- Publication type:
- Article
CRMP2 binding compound accelerates functional recovery from central nervous system damage.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 4, p. 244, doi. 10.1254/fpj.22011
- By:
- Publication type:
- Article
Role of NO-cGMP-PKG axis in pulmonary arterial hypertension.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 4, p. 221, doi. 10.1254/fpj.22018
- By:
- Publication type:
- Article
Optical inactivation of molecular functions in vivo by chromophore-assisted light inactivation.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 4, p. 238, doi. 10.1254/fpj.22009
- By:
- Publication type:
- Article
Tolvaptan, a vasopressin V<sub>2</sub> receptor antagonist, is the world's first approved drug for treatment of autosomal dominant polycystic kidney disease (ADPKD).
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 4, p. 254, doi. 10.1254/fpj.22006
- By:
- Publication type:
- Article
Challenges in kidney disease: therapeutic potential of bardoxolone methyl.
- Published in:
- Folia Pharmacologica Japonica, 2022, v. 157, n. 4, p. 261, doi. 10.1254/fpj.22007
- By:
- Publication type:
- Article